Matinas BioPharma Holdings (MTNB) Short-term Investments (2016 - 2026)

Matinas BioPharma Holdings (MTNB) has 11 years of Short-term Investments data on file, last reported at $50000.0 in Q1 2026.

• Short-term Investments for Q1 2026 came in at $50000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $50000.0 (changed 0.0% YoY), and the FY2025 annual result was $50000.0, changed 0.0% from the prior year.
• Short-term Investments held at $50000.0 in Q1 2026 per MTNB's latest filing, from $50000.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $28.1 million in Q2 2022 and troughed at $50000.0 in Q4 2022.
• A 5-year average of $6.3 million and a median of $50000.0 in 2022 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 17838.0% in 2023 and fell as far as 99.8% in 2023.
• A 5-year view of Short-term Investments shows it stood at $50000.0 in 2022, then soared by 17838.0% to $9.0 million in 2023, then plunged by 99.44% to $50000.0 in 2024, then changed by 0.0% to $50000.0 in 2025, then changed by 0.0% to $50000.0 in 2026.
• Business Quant data shows MTNB's Short-term Investments at $50000.0 in Q1 2026, $50000.0 in Q4 2025, and $50000.0 in Q3 2025.